Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha
- PMID: 11723115
- DOI: 10.1074/jbc.M106339200
Expression of the osteoblast differentiation factor RUNX2 (Cbfa1/AML3/Pebp2alpha A) is inhibited by tumor necrosis factor-alpha
Abstract
The transcription factor RUNX2 (Cbfa1/AML3/Pebp2alphaA) is a critical regulator of osteoblast differentiation. We investigated the effect of the inflammatory cytokine tumor necrosis factor alpha (TNF) on the expression of RUNX2 because TNF is known to inhibit differentiation of osteoblasts from pluripotent progenitor cells. TNF treatment of fetal calvaria precursor cells or MC3T3-E1 clonal pre-osteoblastic cells caused a dose-dependent suppression of RUNX2 steady state mRNA as measured by reverse transcription-PCR. The IC(50) for TNF inhibition was 0.6 ng/ml. TNF suppression of RUNX2 mRNA was confirmed using Northern analysis. The effect of TNF was studied using isoform-specific primers that flanked unique regions of two major RUNX2 isoforms. TNF suppressed expression of the mRNA coding for the shorter MRIPV isoform by >90% while inhibiting expression of the mRNA for the longer MASNS isoform by 50%. RUNX2 nuclear content was evaluated by electrophoretic mobility shift assay using a rat osteocalcin promoter binding sequence as probe and by Western analysis. TNF reduced nuclear RUNX2 protein. Inhibition of new protein synthesis with cycloheximide failed to prevent TNF inhibition of RUNX2 mRNA, suggesting that a newly translated protein did not mediate the TNF effect. RUNX2 mRNA half-life was 1.8 h and reduced to 0.9 h by TNF. The effect of TNF on RUNX2 gene transcription was evaluated using a 0.6-kb RUNX2 promoter-luciferase reporter in MC3T3-E1 cells. TNF caused a dose-dependent inhibition of transcription to 50% of control values. The inhibitory effect of TNF was preserved with deletions to nucleotide -108 upstream of the translational start site; however, localization downstream of nucleotide -108 was obscured by loss of basal activity. Our results indicate that TNF regulates RUNX2 expression at multiple levels including destabilization of mRNA and suppression of transcription. The disproportionate inhibition of RUNX2 nuclear protein suggests that additional post-transcriptional mechanisms may be occurring. Suppression of RUNX2 by TNF may decrease osteoblast differentiation and inhibit bone formation in TNF excess states.
Similar articles
-
Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2.J Biol Chem. 2002 Sep 27;277(39):36181-7. doi: 10.1074/jbc.M206057200. Epub 2002 Aug 28. J Biol Chem. 2002. PMID: 12110689
-
Changes in Runx2/Cbfa1 expression and activity during osteoblastic differentiation of human bone marrow stromal cells.J Bone Miner Res. 2003 Feb;18(2):213-21. doi: 10.1359/jbmr.2003.18.2.213. J Bone Miner Res. 2003. PMID: 12568398
-
Menin is required for bone morphogenetic protein 2- and transforming growth factor beta-regulated osteoblastic differentiation through interaction with Smads and Runx2.J Biol Chem. 2004 Sep 24;279(39):40267-75. doi: 10.1074/jbc.M401312200. Epub 2004 May 18. J Biol Chem. 2004. PMID: 15150273
-
Expression of the PEBP2alphaA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells.Bone. 1998 Feb;22(2):87-92. doi: 10.1016/s8756-3282(97)00267-6. Bone. 1998. PMID: 9477230
-
Post-Translational Regulations of Transcriptional Activity of RUNX2.Mol Cells. 2020 Feb 29;43(2):160-167. doi: 10.14348/molcells.2019.0247. Mol Cells. 2020. PMID: 31878768 Free PMC article. Review.
Cited by
-
Osteoblast role in the pathogenesis of rheumatoid arthritis.Mol Biol Rep. 2021 Mar;48(3):2843-2852. doi: 10.1007/s11033-021-06288-y. Epub 2021 Mar 27. Mol Biol Rep. 2021. PMID: 33774802 Free PMC article. Review.
-
Differential Effects of Inflammation on Bone and Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis.Curr Rheumatol Rep. 2016 Dec;18(12):72. doi: 10.1007/s11926-016-0620-x. Curr Rheumatol Rep. 2016. PMID: 27812955 Review.
-
Targeting tumor necrosis factor receptors in ankylosing spondylitis.Ann N Y Acad Sci. 2019 Apr;1442(1):5-16. doi: 10.1111/nyas.13933. Epub 2018 Jul 15. Ann N Y Acad Sci. 2019. PMID: 30008173 Free PMC article. Review.
-
Liquid flow in scaffold derived from natural source: experimental observations and biological outcome.Regen Biomater. 2022 May 30;9:rbac034. doi: 10.1093/rb/rbac034. eCollection 2022. Regen Biomater. 2022. PMID: 35747746 Free PMC article.
-
The Role of RUNX2 in Osteosarcoma Oncogenesis.Sarcoma. 2011;2011:282745. doi: 10.1155/2011/282745. Epub 2010 Dec 9. Sarcoma. 2011. PMID: 21197465 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources